Science blog

We spoke with Professor Kev Dhaliwal, chief investigator of the SPIKE-1 trial, about how repurposing a drug in a COVID-19 trial could benefit people with cancer.

Recently, news of a COVID-19 vaccine has dominated headlines. We’ve summarised all the information that is out there, with rolling updates, in our new vaccine blog post.

Professor Willie Hamilton specialises in primary care diagnostics at the University of Exeter, with a particular expertise in cancer.

Almost 20 years since Cancer Research UK was founded, not many who worked with McVie remain, but staff know him as the man who gave the charity its beginning.

A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice

We published our gender and ethnicity pay gap reports today.

Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London.

There’s been a steady stream of figures since the pandemic began, each laying bare what many people have seen first-hand – the impact on health services.

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell.